2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow donanemab: new trials by email Literature Review of donanemab trials Research Report on donanemab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Donanemab (LY3002813) in Healthy Participants Donanemab - Healthy | Phase 1 | Completed | Eli Lilly and Company | 42 | 2022-10-04 | 2024-10-04 |
| A Study of Donanemab (LY3002813) in Healthy Chinese Participants Donanemab, Placebo - Healthy | Phase 1 | Completed | Eli Lilly and Company | 36 | 2022-09-14 | 2024-10-04 |
China (1) · United States (1)